Nordic Tuberculosis Testing Market Size & Outlook, 2025-2033
Nordic Tuberculosis Testing Market Insights
- Based on Reed Intelligence findings, the Nordic Tuberculosis Testing Market reached USD 26.14 Million in 2024 and is estimated to attain USD 42.88 Million by 2033.
- From 2026 to 2033, the Nordic market is expected to grow at a steady CAGR of 5.64%.
- Within the By Diagnostic Test Type category, Radiographic Test dominated in 2024 in terms of market size contribution.
- Over the forecast period, Nucleic Acid Test is forecasted to deliver the fastest growth, positioning it as the most lucrative By Diagnostic Test Type segment.
Source: RI Analysis Company Publications, Primary Interviews.
Other Key Findings
- Nordic accounted for 1.33% of the global Tuberculosis Testing Market size in 2024.
- By 2033, United States is expected to remain the top global market in terms of size.
- Within Europe, Germany is forecasted to dominate the regional Tuberculosis Testing Market size by 2033.
- Benelux will be the fastest-growing market in Europe, projected to achieve USD 43.21 Million by 2033.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2024 |
| Study Period | 2021-2033 |
| Historical Period | 2021-2023 |
| Forecast Period | 2025-2033 |
| Market Size In 2024 | USD 26.14 Million |
| Market Size In 2033 | USD 42.88 Million |
| Largest segment | Radiographic Test |
| Units | Revenue in USD Million |
| CAGR | 5.64% (2025-2033) |
| Segmnetation Covered | |
| By Diagnostic Test Type |
|
| By End User |
|
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Nordic Tuberculosis Testing Market By Diagnostic Test Type 2025-2033 (USD Million)
| By Diagnostic Test Type | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Radiographic Test | XX.x | XX.x | XX.x | 7.46 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Smear Microscopy | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Culture-Based Test | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Nucleic Acid Test | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Cytokine Detection Test | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Drug Resistance Test | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Other Diagnostic Test Types | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
Nordic Tuberculosis Testing Market By End User 2025-2033 (USD Million)
| By End User | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital/Clinic | XX.x | XX.x | XX.x | 15.23 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Diagnostics/Research | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: RI Analysis Company Publications, Primary Interviews.
